Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06335966 · ClinicalTrials.gov registry record
BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy
A clinical trial of Esophageal Cancer, sponsored by OHSU Knight Cancer Institute.
- Active
- Registry status
- 110
- Enrollment target
- 1
- Study location
NCT06335966 is a study of Esophageal Cancer that is active but no longer recruiting, run by OHSU Knight Cancer Institute. The registered enrollment target is 110 participants, below the 498-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06335966, a study of Esophageal Cancer, is active but no longer recruiting, sponsored by OHSU Knight Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel approach to screen for Barrett's Esophagus (BE) and Esophageal Carcinoma (EAC) in rural primary care clinic settings in Oregon.
Conditions Studied
Interventions
- DEVICE Screening with swallowable esophageal cell-collection devices (SECD)
Study Locations (1)
Oregon
- OHSU Knight Cancer Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2024-09-11 |
| Est. Completion | 2026-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06335966
The ClinicalTrials.gov registry entry for NCT06335966 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (78% lower). The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Esophageal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Screening with swallowable esophageal cell-collection devices (SECD) is the first listed.
NCT06335966 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06335966 about?
NCT06335966 is a clinical study titled "BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy". Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel...
What is the current status of trial NCT06335966?
This trial is currently active not recruiting. The enrollment target is 110 participants. The study started on 2024-09-11. Estimated completion is 2026-12-30.
What conditions does trial NCT06335966 study?
This clinical trial studies the following conditions: Esophageal Cancer.
What interventions are being tested in trial NCT06335966?
The interventions under investigation include: Screening with swallowable esophageal cell-collection devices (SECD) (DEVICE).
Who is sponsoring clinical trial NCT06335966?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06335966 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
-
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.